Navigation Links
Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
Date:10/12/2010

rent dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients. A3309 is a first-in-class IBAT inhibitor with minimal systemic exposure which is developed for the treatment of CIC and constipation-predominant irritable bowel syndrome (IBS-C).

The primary efficacy endpoint, change from baseline in spontaneous bowel movements (SBMs), showed a dose-dependent increase and highly significant results were obtained for the two highest dose levels. In addition, the secondary endpoints of effects on SBM and complete SBM (CSBM) frequencies were also dose dependent and statistically significant. Bloating and straining, important constipation symptoms, also decreased significantly during A3309 treatment. The effect of A3309 was rapid and a significantly higher proportion of the A3309-treated patients had a CSBM within 24 hours of the first administration. The beneficial effects were maintained over the eight week trial period.

"A3309 has a unique and novel mode of action which utilizes the body's physiologic processes to induce an increase in bowel movements. The results of this Phase IIb study show that A3309 has the potential to be an important therapeutic addition for patients with chronic constipation. I am sure that scientists and clinicians alike look forward to seeing further results with this exciting new compound" said William D. Chey, MD, Professor of Internal Medicine, University of Michigan, Ann Arbor.

"More than 30 million individuals suffer from CIC and IBS-C and the results of this Phase IIb trial further support the potential of A3309 to be an important treatment for these patients. The data in the trial presented today provide a solid base for moving forward into Phase III in 2011" said Hans Graffner, Chief Medical Officer of Albi
'/>"/>

SOURCE Albireo AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation
2. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
3. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
4. Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland
5. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
6. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
7. TriReme Medical Announces $17 Million Series D Financing
8. Warner Chilcott Announces FDA Approval of Next Generation Actonel
9. Arable Corporation Announces New Technology for Clinical Trial Industry
10. PharmaNet Development Group Announces Observational Research Survey
11. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2
(Date:9/1/2014)... Denham Springs, LA (PRWEB) September 01, 2014 ... Crisis Intervention Instructor training, Derek is currently pursuing counselor ... been able to advance through the CPI training program ... Derek states "and I have grown both personally and ... addicts permanently recover, I am competently able to do ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Registration is now ... Warriors® 5K and 1-Mile Race to be held on Sunday, ... Plaza Court Yard at Harmon Meadow in Secaucus, New Jersey. ... Warriors®, a national nonprofit dedicated to restoring a sense of ... service members and our military families. , General registration is ...
(Date:9/1/2014)... Colorado (PRWEB) August 31, 2014 Daily ... an online resource and community that gives members access ... editing resources. , This online resource aims to help ... as well as artists who are looking for inspiration ... Learn more about Tattoo Me Now by visiting the ...
(Date:9/1/2014)... Pastor Thompson is an ordained minister and previously ... is a licensed minister through the Church of the Nazarene ... in New Mexico, Colorado and North Dakota. He and his ... He also has two beautiful daughters, Brianna, 22 and ... from Nazarene Bible College, in Colorado Springs and is currently ...
Breaking Medicine News(10 mins):Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... 25, 2009 Individual nerve cells in the front part ... own for as long as a minute and possibly longer, ... study, available online and appearing in the February issue of ... specific signal that establishes nonpermanent cellular memory and reveals how ...
... environmental hazards are included in the searchable site, , , SUNDAY, ... learn more about the key risk factors for breast cancer, ... you to the available evidence that confirms or quells an ... would be rare for there to be a single environmental ...
... steps to control pain and appearance of varicose veins, expert ... may be hidden by snow pants this time of year, ... to well that warmer weather -- and more revealing clothing ... some predisposed conditions, varicose and spider veins may be inevitable ...
... Asia by VisionQwest , ... Beverly Hills, CA, USA ... to expand its review center operations by opening review centers in ... in the Philippines has started their review services in the area ...
... WASHINGTON, Jan. 23 The following is a ... Senate Subcommittee on State Department And Foreign Operations: ... discriminatory policy that harms many and helps no ... women space births and reduce infant mortality, while ...
... asks, "How many more broken promises lie ahead?"WASHINGTON, Jan. ... solemnly marked the 36th anniversary of the U.S. Supreme ... that has led to the loss of an estimated ... to expand abortion at taxpayers, expense. (Logo: ...
Cached Medicine News:Health News:UT Southwestern researchers discover brain's memory 'buffer' in single cells 2Health News:UT Southwestern researchers discover brain's memory 'buffer' in single cells 3Health News:Database Helps Assess Your Breast Cancer Risk 2Health News:Database Helps Assess Your Breast Cancer Risk 3Health News:What to Do If You Have Unsightly Veins 2Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 2Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 3Health News:VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia 4Health News:FRC Condemns President Obama's $441 Million Bailout of International Abortions 2
Indications For Usage: ,Used to automatically maintain a low intracuff pressure during long-term intubations....
Indications For Usage: ,Microlaryngeal surgery....
... Indications For Usage: ... ,The monitoring lumen is ... of tracheal gases especially end-tidal ... pressure. , Introducing medication. ...
... onset of VAP. (Valles J, Artigas A, ... subglottic secretions in preventing ventilator-associated pneumonia. Ann ... Auboyer C, Jospe R, et al: Prevention ... role of mechanical subglottic secretions drainage and ...
Medicine Products: